NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
AVIR Atea Pharmaceuticals
- 3.160
- +0.020+0.64%
Close Feb 26 16:00 ET
266.90MMarket Cap-1.53P/E (TTM)
3.225High3.105Low259.96KVolume3.140Open3.140Pre Close821.76KTurnover0.38%Turnover RatioLossP/E (Static)84.46MShares4.48052wk High0.58P/B217.12MFloat Cap2.75052wk Low--Dividend TTM68.71MShs Float94.174Historical High--Div YieldTTM3.82%Amplitude2.750Historical Low3.161Avg Price1Lot Size
About Atea Pharmaceuticals Company
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Company Profile
SymbolAVIR
Company NameAtea Pharmaceuticals
Listing DateOct 30, 2020
Issue Price24.00
Founded2012
CEODr. Jean-Pierre Sommadossi,PhD
MarketNASDAQ
Employees75
Fiscal Year Ends12-31
Address225 Franklin Street,Suite 2100
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-857-284-8891
Websitehttp://www.ateapharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Jean-Pierre Sommadossi,PhD
- President, Chief Executive Officer and Chairman of the Board
- 5.93M
- Andrea J. Corcoran
- Chief Financial Officer, Executive Vice President, Legal and Secretary
- 1.96M
- John Vavricka
- Chief Commercial Officer
- --
- Dr. Maria Arantxa Horga, M.D.
- Chief Medical Officer
- 1.85M
- Wayne Foster
- Executive Vice President, Finance and Chief Accounting Officer
- 1.52M
- Dr. Janet Hammond, M.D.,PhD
- Chief Development Officer
- 2.11M
- Arthur Kirsch
- Director
- --
- Bruno Lucidi
- Independent Director
- 324.60K
- Jerome M. Ada M.D.
- Independent Director
- 442.10K
- Franklin M. Berger, C.F.A.
- Lead Independent Director
- 357.10K
- Dr. Polly A. Murphy, D.V.M.,PhD
- Independent Director
- 327.10K
- Barbara G. Duncan
- Independent Director
- 332.10K
- Dr. Bruce Polsky, M.D.
- Independent Director
- 324.60K